Matthew J Robertson Selected Research

Matthew J Robertson Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 01/2019
5	Inflammation (Inflammations) 05/2024 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2021
4	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2020
3	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 01/2022
3	Lung Injury 01/2023 - 01/2022
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2022 - 12/2019
3	Male Infertility (Male Sterility) 12/2020 - 01/2019
2	Pneumonia (Pneumonitis) 05/2024 - 10/2023
2	Emphysema 05/2024 - 10/2023
2	Bronchopulmonary Dysplasia 01/2023 - 12/2022
2	Hyperoxia 01/2023 - 12/2022
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2021
2	Infections 01/2020 - 01/2020
2	Laminopathies 01/2020 - 01/2020
1	COVID-19 01/2023
1	Arthritis (Polyarthritis) 01/2022
1	Heart Failure 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Squamous Cell Carcinoma of Head and Neck 06/2020
1	Gastroenteritis 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Fibrosis (Cirrhosis) 12/2019
1	Sclerosing Cholangitis 12/2019
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2019
1	Myocardial Infarction 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2009
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2019
4	Lamin Type A (Lamin A)IBA 07/2022 - 01/2020
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2021
3	SmokeIBA 05/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	AndrogensIBA 01/2022 - 01/2021
3	Male Contraceptive Agents (Male Contraceptives)IBA 12/2020 - 01/2019
2	SootIBA 05/2024 - 10/2023
2	MicroRNAs (MicroRNA)IBA 05/2024 - 10/2023
2	LipidsIBA 01/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2023 - 12/2022
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 12/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 05/2021 - 01/2021
2	LigandsIBA 01/2021 - 01/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2023
1	Amino Acids FDA Link 01/2023
1	EnzymesIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2023
1	XenobioticsIBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2023
1	LipopolysaccharidesIBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 07/2022
1	Anti-Citrullinated Protein AntibodiesIBA 01/2022
1	MetallothioneinIBA 01/2022
1	ChemokinesIBA 01/2022
1	Syndecan-2IBA 01/2021
1	Protein Tyrosine PhosphatasesIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 06/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	VaccinesIBA 01/2020
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Interferon LambdaIBA 01/2020
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 01/2020
1	MucinsIBA 01/2020
1	Drinking WaterIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	LaminsIBA 12/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2020
2	Castration 01/2022 - 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2009